⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions
globenewswire.com
LYFT
NVS
LLY
RARE
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
globenewswire.com
NVS
How earning a Rutgers Executive MBA motivated an engineer to expand her career ambitions
prnewswire.com
NVS
IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight
globenewswire.com
AMRX
ARX
GSK
AZN
SNY
NVS
MRK
REGN
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
AQST
RAPT
ALGT
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
globenewswire.com
NVS
Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider
globenewswire.com
MRK
AZN
SNY
ROG
NVS
The Multiple Sclerosis Association of America (MSAA) Expands National Reach of Research Initiative to More than 1,000 Participants Across 20 Locations
prnewswire.com
NVS
TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer
globenewswire.com
RPTX
NVS
The Doctors Company Appoints Akhil Saklecha, MD, and Owen Garrick, MD, to Its Board of Governors
prnewswire.com
CVS
MCK
NVS
MRK